Expression of serum amyloid A transcripts in human bone tissues, differentiated osteoblast-like stem cells and human osteosarcoma cell lines

Journal of Cellular Biochemistry

Volumn 103, Issue 3, 2008, Pages 994-1004

  Kovacevic, Alenka ^a   Hammer, Astrid ^a   Stadelmeyer, Elke ^b   Windischhofer, Werner ^a   Sundl, Monika ^a   Ray, Alpana ^c   Schweighofer, Natascha ^a   Friedl, Gerald ^b   Windhager, Reinhard ^b   Sattler, Wolfgang ^a   Malle, Ernst ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

^b UNIVERSITY HOSPITAL GRAZ   (Austria)

^c UNIVERSITY OF MISSOURI   (United States)

Author keywords

Cancer; FPRL 1 ALX; Inflammation; SAA; SAF 1; SR BI

Indexed keywords

CYTOKINE; INTERLEUKIN 1; INTERLEUKIN 6; RNA; SCAVENGER RECEPTOR BI; SERUM AMYLOID A; SERUM AMYLOID A1; SERUM AMYLOID A2; SERUM AMYLOID A4; TRANSCRIPTION FACTOR AP 1; TUMOR NECROSIS FACTOR RECEPTOR; UNCLASSIFIED DRUG;

ADULT; AGED; AMYLOIDOSIS; ARTICLE; BONE DESTRUCTION; BONE MARROW; BONE TISSUE; CARTILAGE DEGENERATION; CELL LINE; CONTROLLED STUDY; CORTICAL BONE; FEMALE; GENE; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE; INFLAMMATION; LIPID METABOLISM; LIVER; MALE; MESENCHYMAL STEM CELL; OSTEOBLAST; OSTEOSARCOMA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SAA GENE; SAA1 GENE; SAA2 GENE; SEQUENCE HOMOLOGY; STEM CELL; TRABECULAR BONE; WESTERN BLOTTING;

ACUTE-PHASE REACTION; AGED; BONE AND BONES; CELL DIFFERENTIATION; CELLS, CULTURED; FEMALE; GENE EXPRESSION; HUMANS; INTERLEUKIN-1; INTERLEUKIN-6; LIVER; MALE; MOLECULAR SEQUENCE DATA; OSTEOBLASTS; OSTEOSARCOMA; RECEPTORS, TUMOR NECROSIS FACTOR; RNA, MESSENGER; SERUM AMYLOID A PROTEIN; STEM CELLS; TRANSCRIPTION, GENETIC; TUMOR MARKERS, BIOLOGICAL; TUMOR NECROSIS FACTOR-ALPHA;

EID: 39049150054     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.21472     Document Type: Article

References (54)

1. Artl A, Marsche G, Lestavel S, Sattler W, Malle E. 2000. Role of serum amyloid A during metabolism of acute-phase HDL by macrophages. Arterioscler Thromb Vasc Biol 20:763-772.
2. Badolato R, Wang JM, Murphy WJ, Lloyd AR, Michiel DF, Bausserman LL, Kelvin DJ, Oppenheim JJ. 1994. Serum amyloid A is a chemoattractant: Induction of migration, adhesion, and tissue infiltration of monocytes and polymorphonuclear leukocytes. J Exp Med 180:203-209.
3. Badolato R, Johnston JA, Wang JM, McVicar D, Xu LL, Oppenheim JJ, Kelvin DJ. 1995. Serum amyloid A induces calcium mobilization and chemotaxis of human monocytes by activating a pertussis toxin-sensitive signaling pathway. J Immunol 155:4004-4010.
4. Baranova IN, Vishnyakova TG, Bocharov AV, Kurlander R, Chen Z, Kimelman ML, Remaley AT, Csako G, Thomas F, Eggerman TL, Patterson AP. 2005. Serum amyloid A binding to CLA-1 (CD36 and LIMPII analogous-1) mediates serum amyloid A protein-induced activation of ERK1/2 and p38 mitogen-activated protein kinases. J Biol Chem 280:8031-8040.
5. Biran H, Friedman N, Neumann L, Pras M, Shainkin-Kestenbaum R. 1986. Serum amyloid A (SAA) variations in patients with cancer: Correlation with disease activity, stage, primary site, and prognosis. J Clin Pathol 39:794-797.
6. Buechler C, Ritter M, Quoc CD, Agildere A, Schmitz G. 1999. Lipopolysaccharide inhibits the expression of the scavenger receptor Cla-1 in human monocytes and macrophages. Biochem Biophys Res Commun 262:251-254.
7. Cho WC, Yip TT, Yip C, Yip V, Thulasiraman V, Ngan RK, Yip TT, Lau WH, Au JS, Law SC, Cheng WW, Ma VW, Lim CK. 2004. Identification of serum amyloid A protein as a potentially useful biomarker to monitor relapse of nasopharyngeal cancer by serum proteomic profiling. Clin Cancer Res 10:43-52.
8. Giner RM, Mancini L, Kamal AM, Perretti M. 2007. Uneven modulation of the annexin 1 system in osteoblast-like cells by dexamethasone. Biochem Biophys Res Commun 354:414-419.
9. Glojnaric I, Casl MT, Simic D, Lukac J. 2001. Serum amyloid A protein (SAA) in colorectal carcinoma. Clin Chem Lab Med 39:129-133.
10. Gutfeld O, Prus D, Ackerman Z, Dishon S, Linke RP, Levin M, Urieli-Shoval S. 2006. Expression of serum amyloid A, in normal, dysplastic, and neoplastic human colonic mucosa: Implication for a role in colonic tumorigenesis. J Histochem Cytochem 54:63-73.
11. Haynesworth SE, Baber MA, Caplan AI. 1992. Cell surface antigens on human marrow-derived mesenchymal cells are detected by monoclonal antibodies. Bone 13:69-80.
12. Hershkoviz R, Preciado-Patt L, Lider O, Fridkin M, Dastych J, Metcalfe DD, Mekori YA. 1997. Extracellular matrix-anchored serum amyloid A preferentially induces mast cell adhesion. Am J Physiol 273:C179-C187.
13. Howard BA, Wang MZ, Campa MJ, Corro C, Fitzgerald MC, Patz EF, Jr. 2003. Identification and validation of a potential lung cancer serum biomarker detected by matrix-assisted laser desorption/ionization-time of flight spectra analysis. Proteomics 3:1720-1724.
14. Hrzenjak A, Artl A, Knipping G, Kostner G, Sattler W, Malle E. 2001. Silent mutations in secondary Shine-Dalgarno sequences in the cDNA of human serum amyloid A4 promotes expression of recombinant protein in Escherichia coli. Protein Eng 12:949-952.
15. Husebekk A, Skogen B, Husby G, Marhaug G. 1985. Transformation of amyloid precursor SAA to protein AA and incorporation in amyloid fibrils in vivo. Scand J Immunol 21:283-287.
16. Jaiswal N, Haynesworth SE, Caplan AI, Bruder SP. 1997. Osteogenic differentiation of purified, culture-expanded human mesenchymal stem cells in vitro. J Cell Biochem 64:295-312.
17. Kaneti J, Winikoff Y, Zimlichman S, Shainkin-Kestenbaum R. 1984. Importance of serum amyloid A (SAA) level in monitoring disease activity and response to therapy in patients with prostate cancer. Urol Res 12:239-241.
18. Khan N, Cromer CJ, Campa M, Patz EF, Jr. 2004. Clinical utility of serum amyloid A and macrophage migration inhibitory factor as serum biomarkers for the detection of nonsmall cell lung carcinoma. Cancer 101:379-384.
19. Kimura M, Tomita Y, Imai T, Saito T, Katagiri A, Ohara-Mikami Y, Matsudo T, Takahashi K. 2001. Significance of serum amyloid A on the prognosis in patients with renal cell carcinoma. Cancer 92:2072-2075.
20. Kovacevic A, Hammer A, Sundl M, Poster B, Hrzenjak A, Ray A, Ray BK, Sattler W, Malle E. 2006. Expression of serum amyloid A transcripts in human trophoblast and fetal-derived trophoblast-like choriocarcinoma cells. FEBS Lett 580:161-167.
21. Kulterer B, Friedl G, Jandrositz A, Sanchez-Cabo F, Prokesch A, Paar C, Scheideier M, Windhager R, Preisegger KH, Trajanoski Z. 2007. Gene expression profiling of human mesenchymal stem cells derived from bone marrow during expansion and osteoblast differentiation. BMC Genomics 8:70.
22. Kwan Tat S, Padrines M, Theoleyre S, Heymann D, Fortun Y. 2004. IL-6, RANKL, TNF-alpha/IL-1: Interrelations in bone resorption pathophysiology. Cytokine Growth Factor Rev 15:49-60.
23. Le L, Chi K, Tyldesley S, Flibotte S, Diamond DL, Kuzyk MA, Sadar MD. 2005. Identification of serum amyloid A as a biomarker to distinguish prostate cancer patients with bone lesions. Clin Chem 51:695-707.
24. Lee MS, Yoo SA, Cho CS, Suh PG, Kim WU, Ryu SH. 2006. Serum amyloid A binding to formyl peptide receptor-like 1 induces synovial hyperplasia and angiogenesis. J Immunol 177:5585-5594.
25. Li BQ, Wetzel MA, Mikovits JA, Henderson EE, Rogers TJ, Gong W, Le Y, Ruscetti FW, Wang JM. 2001. The synthetic peptide WKYMVm attenuates the function of the chemokine receptors CCR5 and CXCR4 through activation of formyl peptide receptor-like 1. Blood 97:2941-2947.
26. Li Y, Dang TA, Shen J, Perlaky L, Hicks J, Murray J, Meyer W, Chintagumpala M, Lau CC, Man TK. 2006. Identification of a plasma proteomic signature to distinguish pediatric osteosarcoma from benign osteochondroma. Proteomics 6:3426-3435.
27. Malle E, De Beer FC. 1996. Human serum amyloid A (SAA) protein: A prominent acute-phase reactant for clinical practice. Eur J Clin Invest 26:427-435.
28. Malle E, Steinmetz A, Raynes JG. 1993. Serum amyloid A (SAA): An acute phase protein and apolipoprotein. Atherosclerosis 102:131-146.
29. 3+ as a specific probe for time-resolved fluorometric immunoassay. J Immunol Methods 182:131-144.
30. Malle E, Leonhard B, Knipping G, Sattler W. 1999. Effects of cytokines, butyrate and dexamethasone on serum amyloid A and apolipoprotein A-I synthesis in human HUH-7 hepatoma cells. Scand J Immunol 50:183-187.
31. Marsche G, Frank S, Raynes JG, Kozarsky KF, Sattler W, Malle E. 2007. The lipidation status of acute-phase protein serum amyloid A determines cholesterol mobilization via scavenger receptor class B, type I. Biochem J 402:117-124.
32. McLean M, Wallace HL, Sharma A, Hill HC, Sabel MS, Egilmez NK. 2004. A BALB/c murine lung alveolar carcinoma used to establish a surgical spontaneous metastasis model. Clin Exp Metastasis 21:363-369.
33. Meek RL, Urieli-Shoval S, Benditt EP. 1994. Expression of apolipoprotein serum amyloid A mRNA in human atherosclerotic lesions and cultured vascular cells: Implications for serum amyloid A function. Proc Natl Acad Sci USA 91:3186-3190.
34. Migita K, Kawabe Y, Tominaga M, Origuchi T, Aoyagi T, Eguchi K. 1998. Serum amyloid A protein induces production of matrix metalloproteinases by human synovial fibroblasts. Lab Invest 78:535-539.
35. Nishie A, Masuda K, Otsubo M, Migita T, Tsuneyoshi M, Kohno K, Shuin T, Naito S, Ono M, Kuwano M. 2001. High expression of the Cap43 gene in infiltrating macrophages of human renal cell carcinomas. Clin Cancer Res 7:2145-2151.
36. O'Hara R, Murphy EP, Whitehead AS, FitzGerald O, Bresnihan B. 2004. Local expression of the serum amyloid A and formyl peptide receptor-like 1 genes in synovial tissue is associated with matrix metalloproteinase production in patients with inflammatory arthritis. Arthritis Rheum 50:1788-1799.
37. Park YB, Park MJ, Kimura K, Shimizu K, Lee SH, Yokota J. 2002. Alterations in the INK4a/ARF locus and their effects on the growth of human osteosarcoma cell lines. Cancer Genet Cytogenet 133:105-111.
38. Patel H, Fellowes R, Coade S, Woo P. 1998. Human serum amyloid A has cytokine-like properties. Scand J Immunol 48:410-418.
39. Pautke C, Schieker M, Tischer T, Kolk A, Neth P, Mutschler W, Milz S. 2004. Characterization of osteosarcoma cell lines MG-63, Saos-2 and U-2 OS in comparison to human osteoblasts. Anticancer Res 24:3743-3748.
40. Ray BK, Murphy R, Ray P, Ray A. 2002. SAF-2, a splice variant of SAF-1, acts as a negative regulator of transcription. J Biol Chem 277:46822-46830.
41. Ray A, Kumar D, Ray P, Ray BK. 2004a. Transcriptional activity of serum amyloid A-activating factor-1 is regulated by distinct functional modules. J Biol Chem 279:54637-54646.
42. Ray A, Shakya A, Kumar D, Ray BK. 2004b. Overexpression of serum amyloid A-activating factor 1 inhibits cell proliferation by the induction of cyclin-dependent protein kinase inhibitor p21WAF-1/Cip-1/Sdi-1 expression. J Immunol 172:5006-5015.
43. Ray A, Bal BS, Ray BK. 2005. Transcriptional induction of matrix metalloproteinase-9 in the chondrocyte and synoviocyte cells is regulated via a novel mechanism: Evidence for functional cooperation between serum amyloid A-activating factor-1 and AP-1. J Immunol 175:4039-4048.
44. Rosenthal CJ, Sullivan LM. 1979. Serum amyloid A to monitor cancer dissemination. Ann Intern Med 91:383-390.
45. Sevetson B, Taylor S, Pan Y. 2004. Cbfa1/RUNX2 directs specific expression of the sclerosteosis gene (SOST). J Biol Chem 279:13849-13858.
46. Shainkin-Kestenbaum R, Berlyne G, Zimlichman S, Sorin HR, Nyska M, Danon A. 1991. Acute phase protein, serum amyloid A, inhibits IL-1- and TNF-induced fever and hypothalamic PGE2 in mice. Scand J Immunol 34:179-183.
47. Stix B, Kahne T, Sletten K, Raynes J, Roessner A, Röcken C. 2001. Proteolysis of AA amyloid fibril proteins by matrix metalloproteinases-1, -2, and -3. Am J Pathol 159:561-570.
48. Uhlar CM, Whitehead AS. 1999. Serum amyloid A, the major vertebrate acute-phase reactant. Eur J Biochem 265:501-523.
49. Uhlar CM, Burgess CJ, Sharp PM, Whitehead AS. 1994. Evolution of the serum amyloid A (SAA) protein superfamily. Genomics 19:228-235.
50. Vallon R, Freuler F, Desta-Tsedu N, Robeva A, Dawson J, Wenner P, Engelhardt P, Boes L, Schnyder J, Tschopp C, Urfer R, Baumann G. 2001. Serum amyloid A (apoSAA) expression is up-regulated in rheumatoid arthritis and induces transcription of matrix metalloproteinases. J Immunol 166:2801-2807.
51. Vermes C, Jacobs JJ, Zhang J, Firneisz G, Roebuck KA, Giant TT. 2002. Shedding of the interleukin-6 (IL-6) receptor (gp80) determines the ability of IL-6 to induce gp130 phosphorylation in human osteoblasts. J Biol Chem 277:16879-81687.
52. Wadsack C, Hrzenjak A, Hammer A, Hirschmugl B, Levak-Frank S, Desoye G, Sattler W, Malle E. 2003. Trophoblast-like human choriocarcinoma cells serve as a suitable in vitro model for selective cholesteryl ester uptake from high density lipoproteins. Eur J Biochem 270:451-462.
53. Weinstein PS, Skinner M, Sipe JD, Lokich JJ, Zamcheck N, Cohen AS. 1984. Acute-phase proteins or tumour markers: The role of SAA, SAP, CRP and CEA as indicators of metastasis in a broad spectrum of neoplastic diseases. Scand J Immunol 19: 193-198.
54. Zerega B, Pagano A, Pianezzi A, Ulivi V, Camardella L, Cancedda R, Cancedda FD. 2004. Expression of serum amyloid A in chondrocytes and myoblasts differentiation and inflammation: Possible role in cholesterol homeostasis. Matrix Biol 23:35-46.